FDA Inspection 1298584 — Rubi Khaw Li, MD
The FDA completed an inspection of Rubi Khaw Li, MD on January 16, 2026 in Quezon City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 16, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Quezon City (Philippines)
Additional Details
Clinical Investigator (CI)